HempMeds: EXCLUSIVE: Medical Marijuana, Inc. Subsidiary HempMeds Working With Argentine Research Hospital On CBD For Adult Epilepsy

Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds is collaborating with Hospital del Cruce to conduct a study in Argentina on the efficiency of CBD as a treatment for epilepsy in adults. The Argentine Ministry of Health authorized Hospital del Cruce, the leading research center in Argentina, to import HempMeds products and conduct the study to be led by Dr. Silvia Kochen, a neurologist who serves as executive director of Neuroscience and Systems Studies Complexes in the Epilepsy Center of Hospital del Cruce. Dr. Kechen's work will form part of a broad scientific evidence initiative on ...Full story available on Benzinga.com